QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
The ISPOR Value Flower: Blooming or withering in today´s healthcare landscape?
In an era where healthcare decisions are becoming increasingly complex, the ISPOR Value Flower offers a refreshing perspective on how we assess the true value of medical interventions.
What is it?
The Value Flower is a conceptual model that expands beyond traditional cost-effectiveness analyses. Its “petals” represent various dimensions of value, most of which are not taken into account in traditional decision making.
Why is it more relevant than ever?
1. Holistic View: […]
Quantify is looking forward to seeing you at the Esmo congress!
In just a few days, Quantify’s Johan Liseth Hansen and Oskar Ström will be heading to the ESMO – European Society for Medical Oncology Congress 2024 to present some of Quantify’s recent oncology research and highlight our world-renowned Oncology Research Platform.
Will we see you there? Get in touch to book a meeting!
Quantify Research Announces Strategic Partnership with Inka Health to Elevate Real- World Evidence and HEOR capabilities
Quantify Research is pleased to announce a new strategic partnership with Inka Health, a leader in health outcomes research providing advanced analytical solutions that support evidence-based decision-making. This collaboration is designed to combine the strengths of both companies to deliver enhanced analytical solutions and software tools to the healthcare sector. Quantify Research, headquartered in Stockholm, Sweden, is […]
Don´t miss out! Limited spots remaining for our event “How can RWE be used in applications to the medicines council?”
Quantify Research is excited to host its next morning meeting on 9 October in Copenhagen! Denmark has unique registry data, but there is uncertainty about how to best use it to create quality evidence for decision-making. In this session, we will explore the possibilities in this rapidly evolving area at this meeting.
We are happy to have a truly fantastic panel of speakers including Niels Christian Hirsch ( […]